Product InformationRegistration Status: Active
DBL HYOSCINE INJECTION BP 400mcg/ML is approved to be sold in Singapore with effective from 1989-12-07. It is marketed by HOSPIRA SINGAPORE PTE LTD, with the registration number of SIN03610P.
This product contains Hyoscine Hydrobromide 400mcg/ml in the form of INJECTION. It is approved for INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR use.
This product is manufactured by Hospira Australia Pty Ltd in GERMANY, andhameln pharmaceuticals GmbH in AUSTRALIA.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.